Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.

ABSTRACT:

Background

We describe a multidisciplinary approach for comprehensive care of amputees with concurrent targeted muscle reinnervation (TMR) at the time of amputation.

Methods

Our TMR cohort was compared to a cross-sectional sample of unselected oncologic amputees not treated at our institution (N = 58). Patient-Reported Outcomes Measurement Information System (NRS, PROMIS) were used to assess postamputation pain.

Results

Thirty-one patients underwent amputation with concurrent TMR during the study; 27 patients completed pain surveys; 15 had greater than 1 year follow-up (mean follow-up 14.7 months). Neuroma symptoms occurred significantly less frequently and with less intensity among the TMR cohort. Mean differences for PROMIS pain intensity, behavior, and interference

SUBMITTER: Alexander JH 

PROVIDER: S-EPMC7701996 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature